Close [X]
Companies & Industry »Company News»Company News Details
Company News Details

BSE   21 Oct 16 | 12:00 AM

391.65 2.8 (0.72%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   21 Oct 16 | 12:00 AM

391.60 3.35 (0.86%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 392.05 (-0.10%)
1 Month : Rs 391.75 (-0.03%)
1 Year : Rs 442.85 (-11.56%)
change companytradenow

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine


Company Price Gain (%)
Hind. Unilever851.101.26
HDFC Bank1,270.351.19
Dr Reddy's Labs3,108.851.08

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine